Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

15.72
Delayed Data
As of Feb 24
 +0.35 / +2.28%
Today’s Change
8.37
Today|||52-Week Range
19.62
+13.67%
Year-to-Date
3 Stocks We're Watching in the First Quarter
Feb 14 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close15.37
Today’s open15.33
Day’s range15.18 - 15.81
Volume532,405
Average volume (3 months)664,133
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+96.24%
Earnings growth (this year)-3,055.01%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)+468.89%
P/E ratioNM
Price/Sales10.61
Price/Book5.70

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-0.45-1.03%
HCMHutchison China Medi...-0.06-0.45%
TBPHTheravance Biopharma...+0.10+0.33%
SRPTSarepta Therapeutics...+1.87+6.20%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$130.0M
Annual profit (last year)-$4.7M
Net profit margin-3.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts


Search for Jobs